Vimarsana
Biggest News Aggregation in the World

Page 41 - Outlayer Item News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outlayer Item Today - Breaking & Trending Today

Women with cystic fibrosis have higher rates of pulmonary exacerbations - Vimarsana News

Women with cystic fibrosis have higher rates of pulmonary exacerbations

Women with cystic fibrosis have higher rates of pulmonary exacerbations compared with men, with differences appearing early in life, researchers reported at the virtual North American Cystic Fibrosis Conference.Researchers conducted a retrospective cohort study utilizing data from the Cystic Fibrosis Foundation Patient Registry from 2006 to 2019. Among 40,782 individuals with cystic fibrosis, the

Source: healio.com
Neoadjuvant chemotherapy may be optimal first-line treatment in advanced ovarian cancer - Vimarsana News

Neoadjuvant chemotherapy may be optimal first-line treatment in advanced ovarian cancer

Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative effectiveness research study in JAMA Oncology.The difference-in-differences analysis compared cancer programs with high use vs. low use of neoadjuvant chemotherapy (NACT), as researchers understood the

Source: healio.com
Achieving clinician-defined target IOP affects change in visual field - Vimarsana News

Achieving clinician-defined target IOP affects change in visual field

Patients with glaucoma who did not achieve clinician-defined target IOP had more rapid visual field worsening, according to data published in Ophthalmology. While other studies have explored the effects of achieving prespecified target IOP, few have studied the clinician-set target.

Source: healio.com
Cardiovascular warnings common but slower to be issued for FDA-approved cancer drugs - Vimarsana News

Cardiovascular warnings common but slower to be issued for FDA-approved cancer drugs

Although more than 25% of contemporary FDA-approved cancer therapies required cardiovascular warnings, post-marketing issuance of the warnings trailed clinical approval by several years, according to a research letter in JAMA Oncology.“Our findings suggest the need for increased vigilance to potentially limit cardiotoxic events, such as arrhythmias. This is especially important as many

Source: healio.com
Benefits of treating perinatal anxiety disorders 'greatly outweigh' risks - Vimarsana News

Benefits of treating perinatal anxiety disorders 'greatly outweigh' risks

Untreated perinatal anxiety disorders and related stress or depression among mothers pose risks to offspring, according to a presenter at Psych Congress. Kimberly Brandt, DO, PMH-C, a perinatal psychiatrist at the University of Missouri School of Medicine, said the benefits of treating these disorders outweigh potential risks.

Source: healio.com